Cognex director exercises 2,913 RSUs into shares

COGNEX CORP director John Tseng-Chung Lee exercised restricted stock units into common shares.

Accepted by SEC EDGAR 02/24/2026 - 04:52 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

COGNEX CORP director John Tseng-Chung Lee exercised restricted stock units into common shares. He converted 2,913 restricted stock units into 2,913 shares of common stock at a stated price of $0.00 per share. After these transactions, he directly holds 24,820 common shares and 4,817 restricted stock units, which will vest over time based on the original grant schedule.

Insider Trade Summary

2,913 shares exercised/converted

Exercise 2 txns

Insider Lee John Tseng-Chung

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	2,913	$0.00	$0.00
Exercise	Common Stock	2,913	$0.00	$0.00
Holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 4,817 contracts (Direct); Common Stock — 24,820 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
2. F2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did COGNEX CORP (CGNX) director John Tseng-Chung Lee report?

Director John Tseng-Chung Lee reported exercising restricted stock units into common shares. He converted 2,913 restricted stock units into 2,913 shares of Cognex common stock at a stated price of $0.00 per share, reflecting a derivative exercise rather than an open-market purchase.

How many COGNEX CORP (CGNX) common shares does John Tseng-Chung Lee own after this transaction?

After the transaction, John Tseng-Chung Lee directly owns 24,820 shares of Cognex common stock. This figure reflects his updated direct common stock position following the exercise and conversion of 2,913 restricted stock units into an equal number of common shares.

What happened to the restricted stock units in the COGNEX CORP (CGNX) filing?

Lee exercised 2,913 restricted stock units, converting them into 2,913 common shares. Following this exercise, he continues to hold 4,817 restricted stock units directly, which remain subject to the original vesting schedule tied to the February 21, 2023 grant date.

Are the COGNEX CORP (CGNX) insider transactions open-market buys or derivative exercises?

The transactions are classified as derivative exercises, not open-market buys. Form data show transaction code “M” and describe the activity as an exercise or conversion of derivative securities, reflecting the conversion of restricted stock units into common stock at a stated price of $0.00 per share.

What is the vesting schedule for the COGNEX CORP (CGNX) restricted stock units mentioned?

The restricted stock units vest in three stages: approximately 20% on the first anniversary, 30% on the second, and 50% on the third anniversary of the February 21, 2023 grant date. This schedule governs when the remaining 4,817 units can convert into common shares.

Does the COGNEX CORP (CGNX) director hold these securities directly or through another entity?

The filing classifies all positions as directly held. Ownership codes and descriptions show direct ownership, and the available footnotes do not indicate any separate trust, partnership, or other entity holding voting or investment power over these Cognex securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee John Tseng-Chung

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/21/2026		M		2,913	A	$0.0	24,820	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/21/2026		M			2,913	02/21/2024(2)	02/21/2026	Common Stock	2,913	$0.0	0	D
Restricted Stock Unit	$0.0							02/17/2027	02/17/2027	Common Stock	4,817		4,817	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

	John Tseng-Chung Lee	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.